Psychological Effects of Implant Loss

Sponsor
Vastra Gotaland Region (Other)
Overall Status
Recruiting
CT.gov ID
NCT04503018
Collaborator
(none)
150
1
70
2.1

Study Details

Study Description

Brief Summary

Previous quality of life studies have suggested that long term satisfaction with breast reconstruction may be affected by postoperative complications. Complication frequencies, especially the risk for implant loss, is considerably higher in immediate than in delayed breast reconstruction. Knowledge about how implant loss affects the patient's experience of her breast reconstruction can guide us in the choice between immediate and delayed breast reconstruction in high risk patients and help us better prepare the patients for possible complications. This study will investigate patients' experiences with losing an implant in connection with immediate breast reconstruction.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Psychological Effects of Implant Loss
    Actual Study Start Date :
    Mar 1, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2025
    Anticipated Study Completion Date :
    Dec 31, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    Interviewed -implant loss

    Patients who have had immediate breast reconstruction and lost the implant due to for example infection.

    Questionnaires - implant loss

    Patients who have had immediate breast reconstruction and lost the implant due to for example infection.

    Questionnaires - controls

    Patients who have had immediate breast reconstruction without complications

    Outcome Measures

    Primary Outcome Measures

    1. Experiences and psychological effects of implant loss after immediate breast reconstruction [10 years]

      Interviews

    2. Effect on quality of life of implant loss: scale [10 years]

      Breast-Q reconstruction post-operative. It includes different domains: health-related quality of life (HR-QOL; including physical, psychosocial, and sexual well-being) and patient satisfaction (including satisfaction with breasts, outcome, and care). Each scale produces an independent score from 0-100.a higher score means greater satisfaction or better QOL

    3. Effect on body image of implant loss [10 years]

      Body-Esteem Scale for Adolescents and Adults (BESAA). It consists of three subscales: BE-appearance, BE-weight and BE-attribution.The scale has 23 items and the respondents indicated their degree of agreement on a 5-point Likert scale ranging from 0 (never) to 4 (always).High score indicates higher dimensions of the Body Esteem.

    4. Effect on depression and anxiety of implant loss [10 years]

      Hospital Anxiety and Depression scale (HAD).The HADS is a fourteen item scale that generates: Seven of the items relate to anxiety and seven relate to depression.For both scales, scores of less than 7 indicate non-cases. 8-10 mild, 11-14 moderate, 15-21 severe.

    5. Coping strategies [10 years]

      Brief-cope, a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event.Scores are presented for the two overarching coping styles: avoidant and approach.The scale can determine someone's primary coping styles.

    6. Coping strategies [10 years]

      The Life orientation test - revised (Lot-R) is a 10-item scale that measures how optimistic or pessimistic people feel about the future. High values imply optimism.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Biological women

    • Age >18 years

    • Have lost an implant after a mastectomy and immediate breast reconstruction

    Exclusion Criteria:
    • Inability to give informed consent

    • inability to speak and understand Swedish

    • relapse of breast cancer after the reconstruction

    • metastatic disease

    • psychiatric co-morbidity.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Västra Götaland Gothenburg Sweden 413 45

    Sponsors and Collaborators

    • Vastra Gotaland Region

    Investigators

    • Principal Investigator: Emma Hansson, PhD, Göteborg University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vastra Gotaland Region
    ClinicalTrials.gov Identifier:
    NCT04503018
    Other Study ID Numbers:
    • 2019-06214
    First Posted:
    Aug 6, 2020
    Last Update Posted:
    Feb 1, 2022
    Last Verified:
    Aug 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Vastra Gotaland Region

    Study Results

    No Results Posted as of Feb 1, 2022